Glucagon stimulation test as a possible predictor of residual β-cell function

Area of Science:

• Endocrinology
• Pediatrics
• Diabetes Research

Background:

• Type 1 diabetes (T1D) management requires understanding residual beta-cell function.
• Predictive markers for beta-cell function decline are crucial for T1D prognosis.

Purpose of the Study:

• To evaluate the predictive value of C-peptide levels from glucagon stimulation tests (GST) in Japanese children with new-onset T1D.
• To assess the long-term residual beta-cell function in relation to early GST results.

Main Methods:

• Retrospective study of 65 Japanese children with new-onset T1D (age <16 years).
• Glucagon stimulation test (GST) performed within one month of diagnosis.
• Postprandial serum C-peptide levels measured at multiple time points up to 120 months post-diagnosis.

Main Results:

• Specific peak serum C-peptide cutoff values on GST predicted beta-cell destruction at various time points (3-60 months).
• For instance, a cutoff of 0.20 ng/mL predicted beta-cell destruction at 3, 6, and 12 months.
• Multivariate analysis identified peak C-peptide, diabetic ketoacidosis, age, and HbA1c at diagnosis as predictors of residual beta-cell function.

Conclusions:

• Early GST C-peptide levels in Japanese children with T1D are significant predictors of residual beta-cell function.
• These findings can help forecast the rate of beta-cell function decline over time.